...
首页> 外文期刊>Epidemiology and infection >Canine visceral leishmaniasis diagnosis: a comparative performance of serological and molecular tests in symptomatic and asymptomatic dogs
【24h】

Canine visceral leishmaniasis diagnosis: a comparative performance of serological and molecular tests in symptomatic and asymptomatic dogs

机译:犬内脏利什曼病的诊断:有症状和无症状犬的血清学和分子检测的比较性能

获取原文
           

摘要

Although serological assays have been widely used for the diagnosis of canine visceral leishmaniasis (CVL), they present different performances depending on the clinical profile of the dogs. This study evaluated the accuracy of serological tests, immunochromatographic (Dual Path Platform: DPP?) and enzyme-linked immunosorbent (ELISA EIE?), for CVL in relation to the detection of Leishmania DNA through real-time polymerase chain reaction (real-time PCR) in samples from symptomatic and asymptomatic dogs from a non-endemic area in the state of Rio Grande do Sul, Southern Brazil. Serum from 140 dogs (39 symptomatic and 101 asymptomatic) was tested by DPP and ELISA followed by real-time PCR. From a total of 140 samples evaluated, Leishmania DNA was detected by real-time PCR in 41.4% (58/140). Moreover, 67.2% of samples positive in real-time PCR were positive in both DPP and ELISA (39/58), showing moderate agreement between methods. In the symptomatic group, one sample non-reactive in both serological assays was positive in real-time PCR, whereas in the asymptomatic group, 17.8% non-reactive or undetermined samples in serological assays were positive in the molecular method. Leishmania DNA was not detected in 17.9% reactive samples by serological assays from the symptomatic group, and in 3.9% from asymptomatic dogs. Real-time PCR demonstrated greater homogeneity between symptomatic and asymptomatic groups compared with DPP and ELISA. The molecular method can help to establish the correct CVL diagnosis, particularly in asymptomatic dogs, avoiding undesirable euthanasia.
机译:尽管血清学检测已被广泛用于犬内脏利什曼病(CVL)的诊断,但根据狗的临床情况,它们表现出不同的性能。这项研究评估了血清学检测,免疫色谱法(Dual Path Platform:DPP?)和酶联免疫吸附剂(ELISA EIE?)对于通过实时聚合酶链反应(实时)检测利什曼原虫DNA的CVL的准确性。 PCR)来自巴西南部南里奥格兰德州非疫区有症状和无症状犬的样本。通过DPP和ELISA,然后进行实时PCR检测140只狗(39例有症状和101例无症状)的血清。在评估的总共140个样品中,通过实时PCR检测到利什曼原虫DNA的比例为41.4%(58/140)。此外,实时荧光定量PCR阳性样品中67.2%的DPP和ELISA均为阳性(39/58),表明方法之间的一致性中等。在有症状组中,两种血清学测定中无反应的样品在实时PCR中均为阳性,而在无症状组中,血清学测定中17.8%的无反应性或未确定样品在分子方法中均为阳性。通过有症状组的血清学检测,未在17.9%的反应性样品中检出利什曼原虫DNA,而在无症状的狗中未检出3.9%的利什曼原虫DNA。与DPP和ELISA相比,实时PCR显示有症状和无症状组之间的同质性更高。分子方法可以帮助建立正确的CVL诊断,尤其是在无症状的狗中,避免了不希望的安乐死。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号